Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|October 19, 2011
Adjuvant therapy for gallbladder and bile duct cancers: retrospective comparative studyF Tugba Kos, S Aksoy, H Odabas, et al.Asian Pacific Journal of Cancer Prevention : APJCP|March 8, 2013
Is there an association between blood group and survival in pancreatic cancer?F Tugba Kos, Burak Civelek, M Metin Seker, et al.Wiener Klinische Wochenschrift|November 20, 2013
Evaluation of the effect of comorbidity on survival in pancreatic cancer by using "Charlson Comorbidity Index" and "Cumulative Illness Rating Scale"F Tugba Kos, Ozan Yazici, Burak Civelek, et al.Chemotherapy|May 21, 2011
Comparison of cisplatin-5-fluorouracil-folinic acid versus modified docetaxel-cisplatin-5-fluorouracil regimens in the first-line treatment of metastatic gastric cancerF Tugba Kos, Dogan Uncu, Nuriye Ozdemir, et al.Wiener Klinische Wochenschrift|February 28, 2015
Prognostic role of pretreatment platelet/lymphocyte ratio in patients with non-small cell lung cancerMehmet Kos, Cemil Hocazade, F Tugba Kos, et al.Contemporary Oncology (Poznan, Poland)|July 1, 2016
Evaluation of the effects of red blood cell distribution width on survival in lung cancer patientsMehmet Kos, Cemil Hocazade, F Tugba Kos, et al.Asian Pacific Journal of Cancer Prevention : APJCP|April 30, 2013
Evaluation of renal function using the level of neutrophil gelatinase-associated lipocalin is not predictive of nephrotoxicity associated with cisplatin-based chemotherapyF Tugba Kos, Mehmet Ali Nahit Sendur, Sercan Aksoy, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|December 24, 2014
Adjuvant chemotherapy outcomes in patients over 65 years with early stage colorectal carcinomaBurak Civelek, Sercan Aksoy, Mehmet Ali Nahit Sendur, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|April 25, 2013
Administration of contrast media just before cisplatin-based chemotherapy increases cisplatin-induced nephrotoxicityM A N Sendur, S Aksoy, S Yaman, et al.Asian Pacific Journal of Cancer Prevention : APJCP|August 21, 2012
Long term survivors with metastatic pancreatic cancer treated with gemcitabine alone or plus cisplatin: a retrospective analysis of an Anatolian Society of Medical Oncology multicenter studyAli Inal, Aydin Ciltas, Ramazan Yildiz, et al.Pageof 1